Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [406]

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested

Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested

EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure

EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

ASCO 2022: Immunotherapy before surgery associated with improved survival for soft-tissue sarcoma

ASCO 2022: Immunotherapy before surgery associated with improved survival for soft-tissue sarcoma

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Researchers shed light on why a certain plant virus is so powerful at fighting cancer

Researchers shed light on why a certain plant virus is so powerful at fighting cancer

Biological pathways found that drive genomic changes and bone metastasis in Ewing sarcoma, a rare childhood cancer

Biological pathways found that drive genomic changes and bone metastasis in Ewing sarcoma, a rare childhood cancer

Lab findings suggest EGFR inhibitors may prevent rhabdomyosarcoma recurrence

Lab findings suggest EGFR inhibitors may prevent rhabdomyosarcoma recurrence

More from ecancer